Research@Queen’s: Clinical trials for game-changing cancer research

Research@Queen’s: Clinical trials for game-changing cancer research

To recognize World Cancer Day, Queen’s is profiling the Canadian Cancer Trials Group and its role in facilitating cancer clinical trials that lead to better outcomes and quality of life for cancer patients globally.

By Mark Witten

February 4, 2021


[Illustration by Gary Neill of petri dishes]
Illustration by Gary Neill
Discover Research@Queen’s
Did you know that the university launched a central website for Queen’s research? From in-depth features to the latest information on how our researchers are confronting COVID-19, the site is a destination showcasing the impact of Queen’s research. Discover Research@Queen’s.

Will exercise help prevent colorectal cancer from coming back? Can a new blood test for DNA markers predict which prostate cancer patients will be helped most by experimental targeted therapies? Is it safe for young women with breast cancer who wish to become pregnant to temporarily interrupt endocrine therapy to try to have a baby? Will a new four-drug combination save the lives of more pancreatic cancer patients after surgery?

The Canadian Cancer Trials Group (CCTG), headquartered at Queen’s University, asks and finds evidence-based answers to critical questions about the best treatment options for the 225,000 Canadians diagnosed with cancer each year. Innovations proven to be effective through CCTG led clinical trials have set new standards of care that guide treatment decisions for patients today and tomorrow: curing disease, preventing recurrence, saving lives, and improving quality of life.

Continue the story on the Research@Queen’s website.

Health Sciences